Niusule Biotech announces financial guidance for year ending December 31, 2010

NewsGuard 100/100 Score

Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").

Based on current trends and planned expansion of its retail distribution network, Niusule management is now forecasting that revenue for CY 2010 is expected to be approximately $10 million. The Company estimates gross margin to be in the range of 70%-75% with net income of $2.5 to $3.0 million for CY 2010. The Company's current guidance is subject to financing.

Niusule's Gummy Bear products have been well received in China and are quickly gaining popularity. In just over a month since its launch, the Company has expanded its market presence to over 36 retail outlets in Zhejiang Province. The Company has also signed contracts with two leading distributors in Zhejiang Province to distribute its products through leading retail outlets, and pharmacies including, Century Lianhua Supermarket, Carrefour, Trust Mart and CRV (China Resources Vanguard) Mart. Under this contract, the Company expects to distribute its products through 100 retail outlets in Zhejiang province and Shanghai city, including 50 pharmacies by the end of year 2009 and reach a total of 250 retail outlets by the year 2010. In 2011, the Company plans to add new markets, including the Beijing City, Guangdong Province and Jiangsu Province. Niusule expects to invest 17% of its CY 2010 revenue in advertising campaigns to establish a strong brand name with a slightly lower level of advertising spending in CY 2011.

"In CY 2010, we expect strong revenue and net income growth as we continue to expand our presence in China and capitalize on the market opportunity available in China's nutritional supplement market," commented Ms. Qinghua Hu, CEO of Niusule Biotech Corp. "Our aggressive market expansion and growth strategy includes, utilizing our flagship Gummy Bears product category to establish a widespread retail network across China. Once established, we intend to utilize this network to introduce new products and enhance our revenue growth and profitability."

Source:

Niusule Biotech Corp.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial in Seattle aims to transform treatment approaches for pediatric IBD